+47 930 54 975
Ann-Tove Kongsnes is an Investment Director and Head of International Affairs at Investinor AS.
Kongsnes has over her career gained extensive experience from investments, development, M&A, IPO’s and exits of technology companies. Before this, she worked 7 years in international marketing, serving as Director of Marketing and Operations. Kongsnes has broad boardroom experience, and currently serves on the boards of Investinor’s portfolio companies, Numascale AS, Vitux AS, Spinchip Diagnostics AS, Shelterwood AS and poLight ASA (listed on Oslo Stock Exchange).
She is also Chair of the Nomination Committee in Novelda AS and a member of the Nomination Committee in Bergenbio ASA (listed Oslo Stock Exchange), Calliditas Therapeutics AB (listed company on Nasdaq, Stockholm) and Phoenix AS. She holds an MSc in Economics and Business Administration from Bodø University College (HiB) and has completed the Advanced Program in Corporate Finance at Norwegian School of Economics (NHH).